Analyst
Basic Information
Brief Name:
ANALYST
Impact Factor:
3.6
ISSN:
0003-2654
Research Field:
CHEMICAL
h-index:
137
Self-citation Rate:
5.6%
Articles per Year:
653
SCI Index Status:
Science Citation Index Expanded
Journal Website:
http://pubs.rsc.org/en/journals/journalissues/an
Journal Introduction:
Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.
CiteScore
CiteScore
7.8
SJR
0.693
SNIP
0.725
| Subject | Rank | Percentile |
|---|---|---|
ChemistrySpectroscopy |
12 / 76 | 84% |
Journal Statistics
Monthly
Issues/Year
Time to first decision (peer reviewed only): 27 days
Review Cycle
£2,750
Article Processing Fee
Submission Information
Submission Website:
http://mc.manuscriptcentral.com/anAccepted Types:
Communications
Full papers
Critical reviews
Tutorial reviews
Minireviews
Comments
Full papers
Critical reviews
Tutorial reviews
Minireviews
Comments
Related Articles
Profiling of human urinary phospholipids by nanoflow liquid chromatography/tandem mass spectrometry
Hanna Kim, Eunjeong Ahn, Myeong Hee Moon
2008-09-03
Paper
DOI: 10.1039/B804715D
Univariate calibration by reversed regression of heteroscedastic data: a case study
Joel Tellinghuisen
2008-10-28
Perspective
DOI: 10.1039/B808667B
Combining chemical reduction with an electrochemical technique for the simultaneous detection of Cr(vi), Pb(ii) and Cd(ii)
Jichao Zhang, Erkang Wang
2008-10-24
Paper
DOI: 10.1039/B804670K
Predicting skin permeability using liposome electrokinetic chromatography
Yongjun Wang, Hongzhuo Liu, Liqiang Zhang, Kai Liu
2008-10-24
Paper
DOI: 10.1039/B807497F
New advances in on-line sample preconcentration by capillary electrophoresis using dynamic pH junction
Adam S. Ptolemy, Philip Britz-McKibbin
2008-10-09
Highlight
DOI: 10.1039/B808236G
A microfluidic technique for monitoring bloodstream analytes indicative of C-peptide resistance in type 2 diabetes
Teresa D'Amico Oblak, Jennifer A. Meyer, Dana M. Spence
2008-11-27
Paper
DOI: 10.1039/B816740K
Recommended Compounds
![887405-40-5 - 2-{[(1r,3R,5S,7r)-3,5-Dimethyladamantan-1-yl]oxy}ethanamine](/structs/887/887405-40-5-bd8a.webp "887405-40-5 - 2-{[(1r,3R,5S,7r)-3,5-Dimethyladamantan-1-yl]oxy}ethanamine")
![52234-82-9 - 2,2-Bis({[3-(1-aziridinyl)propanoyl]oxy}methyl)butyl 3-(1-aziridinyl)propanoate](/structs/522/52234-82-9-af4e.webp "52234-82-9 - 2,2-Bis({[3-(1-aziridinyl)propanoyl]oxy}methyl)butyl 3-(1-aziridinyl)propanoate")
![89483-07-8 - 3-Cyclopropyl-N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-alanine - N-cyclohexylcyclohexanamine (1:1)](/structs/894/89483-07-8-8d6f.webp "89483-07-8 - 3-Cyclopropyl-N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-alanine - N-cyclohexylcyclohexanamine (1:1)")
![690632-12-3 - 1-[2-(3-Chlorophenyl)-1,3-thiazol-4-yl]methanamine hydrochloride hydrate](/structs/690/690632-12-3-17fd.webp "690632-12-3 - 1-[2-(3-Chlorophenyl)-1,3-thiazol-4-yl]methanamine hydrochloride hydrate")
![103775-14-0 - (3S)-2-{N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl}-6,7-dimethoxy-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid](/structs/103/103775-14-0-c321.webp "103775-14-0 - (3S)-2-{N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl}-6,7-dimethoxy-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid")
Recommended Suppliers
Shanghai Baiyi Chemical Co., Ltd.
Borer Chemie AG
Aker Process B.V.Golden Sea Iodine Chemical (Qingdao) Co., Ltd.
Rixius AGShandong Jiuyue BioTechnology Co., Ltd.Shanghai Kemwiong International Trade Co., Ltd
AAPPTec, LLCHangzhou Chuanfu Press Filter Machine Co., Ltd.Sichuan Hongya Qingyi Jiang Chemical Industry Co., Ltd.Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at [email protected]. We will promptly review and address your concerns.